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Background: Rapid infusion of warmed blood products is the cornerstone of
trauma resuscitation and treatment of surgical and obstetric massive hemor-
rhage. Integral to optimizing this delivery is selection of an intravenous
(IV) catheter and use of a rapid infusion device (RID). We investigated which
IV catheter and RID system enabled the greatest infusion rate of blood prod-
ucts and the governing catheter characteristics.
Study Design and Methods: The maximum flow rates of nine IV catheters
were measured while infusing a mixture of packed red blood cells and fresh
frozen plasma at a 1:1 ratio using a RID with and without a patient line exten-
sion. To account for IV catheters that achieved the RID's maximum 1000 ml/
min, the conductance of each infusion circuit configuration was calculated.
Results: IV catheters of 7-Fr caliber or higher reached the maximum pressur-
ized flow rate. The 9-Fr multi-lumen access catheter (MAC) achieved the
greatest conductance, over sevenfold greater than the 18 g peripheral catheter
(4.6 vs. 0.6 ml/min/mmHg, p < .001). Conductance was positively correlated
with internal radius (β = 1.098, 95% CI 4.286–5.025, p < .001) and negatively
correlated with length (β= − 0.495, 95% CI −0.007 to 0.005, p < .001). Use of
an extension line (β= − 0.094, 95% CI −0.505 to −0.095, p = .005) was inde-
pendently associated with reduced conductance in large caliber catheters.
Conclusion: Short, large-diameter catheters provided the greatest infusion
rates of massive transfusion blood products for the least pressure. For patients
requiring the highest transfusion flow rates, extension tubing should be
avoided when possible.
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1 | INTRODUCTION
A vital step in the resuscitation of patients with major
hemorrhage is achieving adequate intravenous
(IV) access. This refers to the insertion of a catheter capa-
ble of infusing blood products at a sufficient flow rate to
reverse a volume deficit and maintain tissue perfusion
despite ongoing blood loss.
The Hagen–Poiseuille law, which governs laminar
flow rates in noncompressible Newtonian fluids, suggests
that infusion rate should be proportional to the internal
radius of the IV catheter to the fourth power and driving
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pressure, but inversely proportional to the viscosity of the
infusate and length of the catheter. Previous work has
confirmed the impact of these catheter characteristics on
flow rates achievable.1
In more clinically representative models, others
have shown that the Hagen–Poiseuille law is a poor
predictor of in vivo IV catheter performance in part
because commercially available systems at typical
resuscitative flows often involve multiple points along
the infusion path where turbulence is introduced.2
Adding to the difficulty in predicting catheter perfor-
mance is the variation in techniques used by manufac-
turers to generate their stated flow rates; some use
pressure bags while others utilize the hydrostatic pres-
sure of a 100 cm head height.3
The majority of previous studies employed crystalloid,
synthetic colloid, or packed red blood cells at room temper-
ature, with standard administration tubing and pressurized
by means of pressure bags.1–5 However, blood viscosity is
inversely proportional to temperature, and because current
practice in hemostatic resuscitation of trauma patients calls
for the infusion of warmed packed red blood cells and fresh
frozen plasma at an approximate ratio of 1:1, these findings
may not apply directly to all massive resuscitation scenarios.
In addition, many major trauma centers employ the use of
a rapid infusion device (RID), capable of achieving flow
rates of up to 1200 ml/min, while warming to physiologic
temperature. There are notable rheological differences in
infusing warmed, pressurized blood products when com-
pared to crystalloid. The viscosity of blood is not only higher
than that of crystalloids, it varies with shear stress, render-
ing it a non-Newtonian fluid. This, together with the high
probability of turbulence within infused products, reduces
the applicability of the Hagen–Poiseuille law in this
instance.
Rather than attempting to strictly apply the laminar
flow dynamics dictated by the Hagen–Poiseuille law to the
flow of blood, a non-Newtonian fluid, through a complex,
turbulence-inducing tube, we aimed to clarify these con-
cepts for clinicians involved in the management of major
hemorrhage via a pragmatic in vitro assessment of the max-
imum flow rates achievable with different IV catheters
using a resuscitation fluid consisting of a fixed ratio of
warmed blood products and a commercially available RID.
We hypothesized that larger-bore, shorter catheters without
an extension line would afford higher flows of mixed blood
products at lower pressures than smaller-bore, longer cathe-
ters with an extension line. We also used this clinically rep-
resentative system and fluid to investigate factors that
determined flow rates, in particular the effect of IV catheter
characteristics.
2 | MATERIALS AND METHODS
2.1 | General
This in vitro study was exempt from requiring institu-
tional review board approval.
2.2 | IV catheters
Catheters were selected based on their availability at our
level-one trauma center and likelihood of encountering
them during a massive transfusion situation. Physical
TABLE 1 Intravenous catheters characteristics and manufacturers
Catheter Description Manufacturer Material ID (mm) TL (mm)
PVC 18 g Introcan Safety IV Catheter B. Braun Medical (Bethlehem,
PA, USA)
FEP 0.84 32
PVC 16 g Introcan Safety IV Catheter B. Braun Medical (Bethlehem,
PA, USA)
FEP 1.19 32
PVC 14 g Introcan Safety IV Catheter B. Braun Medical (Bethlehem,
PA, USA)
FEP 1.60 50
CVC ARROWguard Blue PLUS Two-Lumen
Central Venous Catheter
Teleflex (Wayne, PA, USA) PU 1.60 300
Trialysis Short Term Dialysis 15 cm Straight Catheter Bard (Covington, GA, USA) PU 2.16 250
7-Fr RIC Arrow Rapid Infusion Catheter Teleflex (Wayne, PA, USA) PU 2.33 50
9-Fr Sheath Arrow sheath Introducer Teleflex (Wayne, PA, USA) PU 3.20 300
9-Fr MAC ARROWguard Blue PLUS Multi-lumen
Access Catheter
Teleflex (Wayne, PA, USA) PU 3.00a 215
Abbreviations: PVC, peripheral venous catheter; CVC, central venous catheter; RIC, rapid infusion catheter; MAC, multi-lumen access catheter; ID, internal
diameter; TL, total length; FEP, fluorinated ethylene propylene; PU, polyurethane.
aOval-shaped lumen is 9-Fr per manufacturer.
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characteristics and manufacturer details of the IV catheters
assessed are provided in Table 1. Per the manufacturers of
the French scale catheters, French refers to the inside diam-
eter. The Teleflex (Wayne, PA, USA) 9-Fr sheath has a
3.20 mm inside diameter per the manufacturer; this mea-
surement was used in calculations. For all other French-
sized catheters, internal diameter (ID) was converted to
mm using the following calculation: mm = Fr/3.
2.3 | Infusion circuit
An infusion circuit (Figure 1) was assembled using the
Belmont FMS 2000 rapid infusion device (RID) and a 3-L
reservoir with a 5-spike connector set (Belmont Instru-
ment Corporation, Billerica, MA, USA). The standard
54-inch patient line was employed for all assessments
and the 54-inch patient line extension tubing (Belmont
Instrument Corporation, Billerica, MA, USA) was added
where indicated. To minimize the volume of blood prod-
ucts required, the infusate was recirculated into the 3-L
reservoir by cutting the single spike tubing and inserting
each of the various IV catheters into the lumen of the
tubing such that the tip hung freely inside the reservoir.
Two catheters (the 9-Fr multi-lumen access catheter
[MAC] and Trialysis catheters) were too wide for the
spike tubing lumen and in this instance the infusate was
collected in an empty normal saline (NS) bag prior to dis-
posal. To minimize variation in hydrostatic pressure
within the infusion circuit, the IV catheters' tips were set
at the same height during each trial.
2.4 | Infusion fluids
Performance of the IV catheters was assessed using NS
(Baxter, Deerfield, IL, USA) and a mixture of expired
packed red blood cells (RBCs) and fresh frozen plasma
(FFP) units at a ratio of 1:1 (R + F [1:1 mixture of RBCs
and FFP]). The mean hematocrit of RBC units was 55%
(personal communication, Esensten, J., Department of
Laboratory Medicine, ZSFG). The mean (standard devia-
tion) number of days beyond expiration date of the R + F
was 4.83 (2.72) for RBCs and 9.17 (4.68) for FFP.
2.5 | Conduct of trials
The maximum flow rate achievable with each IV catheter
and the pressure required to achieve them were measured
using the RID's integral sensors. In catheters with two
lumens of equal caliber, both lumens were assessed, other-
wise only the largest bore lumenwas assessed. All RIDs were
within the service period, and the manufacturer has indi-
cated that the device does not require regular calibration.
The sequence of trials was as follows: all catheters
using NS and standard patient line (SPL) (NS group); all
catheters using R + F and SPL (R + F group); all cathe-
ters using R + F, SPL, and patient line extension (R + F
+ E [R + F with patient line extension] group). This
sequence was repeated on three different RIDs, using
new infusate, reservoir, and patient lines each time.
FIGURE 1 Schematic representation of infusion circuit (not to
scale). I, infusate; IVC, intravenous catheter; R, 3-liter reservoir;
RF, reservoir filter; RID, rapid infusion device; SPL, standard
patient line; SPLE, standard patient line with extension
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2.6 | Calculation of conductance
Several infusion circuit configurations achieved the RID's
maximum flow rate of 1000 ml/min. Consequently, to
normalize the data for analysis, the system conductance
(ml/min/mmHg) was calculated as maximum flow
(ml/min)/pressure at maximum flow (mmHg), in accord
with previous work.6
2.7 | Statistics
Continuous data are presented as mean with standard
deviation. Data analysis was performed with SPSS v23
(IBM, Endicott, USA). Analysis of variance tests were
used for univariate analysis. The relationship between
the infusion circuit configurations and conductance was
assessed by multiple linear regression analysis. All inde-
pendent variables were included in the model. All
p values are two-tailed with an α level of .05. To ensure
our inclusion of NS in the model did not affect potential
relationships between catheter characteristics and con-
ductance, linear regression was repeated with infusion
circuits only using R + F as a sensitivity analysis.
3 | RESULTS
The addition of any catheter to the rapid infusion
device (RID) reduced the maximum flow capabilities of
the infusion circuit (Figure 2) and ranged from
4.6 ml/min/mmHg with the 9-Fr MAC to 0.6 ml/min/
mmHg with the peripheral venous catheter (PVC) 18 g.
Table 2 outlines the mean maximum flow rates and the
pressures at which these were achieved for each config-
uration of the infusion circuit. Catheters with ID of
7-Fr or greater reached the 1000 ml/min maximum
flow rate of the RID; all other catheters' maximum flow
rates were restricted by the RID's integral pressure lim-
itation of 300 mmHg. The conductance of R + F com-
pared to NS was approximately 15% reduced in the
larger bore catheters, whereas the difference was mini-
mal in the smaller bore catheters.
The percentage increase in conductance due to
increasing the ID of the IV catheter is illustrated by
Table 3, using as a reference the PVC 18 g infusing R + F
via a standard patient line without extension. Conduc-
tance was approximately sevenfold higher with the 7-Fr
rapid infusion catheter (RIC) and 9-Fr catheters com-
pared to the PVC 18 g. The only catheter that did not ren-
der a significant increase in flow capability was the
proximal lumen of the central venous catheter (CVC)
14 g catheter.
In general, the addition of the patient line extension
caused a reduction in conductance in the larger bore
catheters of approximately 20% (Table 3); this reached
statistical significance with the 9-Fr sheath and the 7-Fr
RIC, but not the 9-Fr MAC. No significant difference was
observed in conductance between NS and R + F infu-
sions for any catheter tested.
FIGURE 2 Mean conductance of each intravenous catheter using normal saline (NS), 1:1 mixture of RBCs and FFP (R + F), and R + F with
patient line extension (R + F + E). Error bars indicate standard deviation. CVC, central venous catheter; MAC, multi-lumen access catheter; PVC,
peripheral venous catheter; RIC, rapid infusion catheter; R + F, 1:1 mixture of RBCs and FFP; R + F + E, R + F with patient line extension
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Multiple linear regression revealed a significant posi-
tive relationship between the internal radius of the cathe-
ter and conductance (β = 1.098, 95% CI 4.286–5.025,
p < .001); this variable was the most predictive of con-
ductance within the circuit (Table 4). Increasing catheter
length was a significant independent predictor of reduced
conductance (β = −0.495, 95% CI −0.007 to −0.005,
p = .001). Use of R + F was associated with reduced con-
ductance as compared to NS (β = −0.107, 95% CI −0.548
to −0.137, p = .001), as was the addition of the patient
line extension (β = −0.094, 95% CI −0.505 to −0.095,
p = .005). Neither use of a proximal port nor catheter
material were significant predictors of conductance.
The model accounted for 93% of the variance
observed in conductance (adjusted R2 = 0.931) and
assessment of the residuals confirmed normality and
homoscedasticity and excluded multicollinearity. With
the exception of catheter material, all independent signif-
icant predictors of conductance in the original model
remained significant after excluding NS. The changes in
TABLE 3 Percentage difference in mean conductance with changes in catheter (compared with reference [PVC 18 g using R + F and
standard patient line]), infusate (R + F vs. NS), and patient line extension (R + F vs. R + F with patient line extension)
Catheter (%) p valuea Infusate (%) p value Patient line extension (%) p value
PVC 18 g Reference 81 .455 127 .281
PVC 16 g 245 <.001 91 .281 102 .790
PVC 14 g 398 <.001 93 .156 96 .287
CVC 14 g Distal 138 .015 81 .116 101 .959
CVC 14 g Proximal 108 .833 79 .085 104 .791
Trialysis 12 g Distal 481 <.001 94 .269 91 .910
Trialysis 12 g Proximal 455 <.001 91 .217 92 .261
7-Fr RIC 746 <.001 88 .191 77 .029
9-Fr Sheath 697 <.001 87 .131 82 .044
9-Fr MAC 753 <.001 84 .116 83 .087
Abbreviations: NS, normal saline; R + F, 1:1 mixture of RBCs and FFP; R + F + E, R + F with patient line extension; PVC, peripheral venous catheter; CVC,
central venous catheter; RIC, rapid infusion catheter; MAC, multi-lumen access catheter.
ap values from one-way ANOVA.
TABLE 2 Mean maximum flow rate and required pressure for each infusion circuit configuration. Data expressed as mean (standard
deviation)
Catheter













PVC 18 g 226 (65) 300 (0.00) 183 (63.31) 300 (0.00) 231 (22) 300 (0.00)
PVC 16 g 495 (30) 300 (0.00) 448 (57.52) 300 (0.00) 458 (20) 300 (0.00)
PVC 14 g 785 (37) 300 (0.00) 728 (41.63) 300 (0.00) 698 (7) 300 (0.00)
CVC 14 g Distal 311 (16) 300 (0.00) 253 (47.52) 300 (0.00) 255 (21) 300 (0.00)
CVC 14 g Proximal 251 (15) 300 (0.00) 198 (37.53) 300 (0.00) 205 (18) 300 (0.00)
Trialysis 12 g Distal 935 (55) 300 (0.00) 880 (50.00) 300 (0.00) 799 (38) 300 (0.00)
Trialysis 12 g
Proximal
913 (45) 300 (0.00) 833 (83.12) 300 (0.00) 765 (35) 300 (0.00)
7-Fr RIC 1000 (0.00) 195 (15) 1000 (0.00) 221 (24) 1000 (0.00) 287 (12)
9-Fr Sheath 1000 (0.00) 204 (16) 1000 (0.00) 237 (24) 1000 (0.00) 287 (7)
9-Fr MAC 1000 (0.00) 184 (16) 1000 (0.00) 220 (27) 1000 (0.00) 264 (14)
No Catheter 1000 (0.00) 123 (10) 1000 (0.00) 152 (8) 1000 (0.00) 217 (4)
Abbreviations: NS, normal saline; R + F, 1:1 mixture of RBCs and FFP; R + F + E, R + F with patient line extension; PVC, peripheral venous catheter; CVC,
central venous catheter; RIC, rapid infusion catheter; MAC, multi-lumen access catheter.
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catheter internal radius retained the strongest effect on
conductance (β = 1.113, 95% CI 4.003–4.6876, p < .001).
4 | DISCUSSION
The flow capabilities of the IV catheters tested using R
+ F were predominantly governed by their internal
radius. Catheter length was also an important determi-
nant and likely accounts for the smaller bore 7-Fr RIC
performing equal to the 9-Fr sheath; however, an addi-
tional potentially contributing factor is the turbulence-
inducing 90-degree turn built into the sheath. These data
support the widespread practice of inserting short, wide
catheters for massive transfusions in surgical, obstetric,
and trauma patients and underscore the unsuitability of
standard CVCs for large volume resuscitations.
The addition of the patient line extension had a sig-
nificant effect on the conductance of large bore catheters,
in accord with previous work.7 In smaller catheters, the
flow was likely restricted to such a degree by the inner
catheter diameter that additional resistance from
increased path length had little relative impact on the
overall resistance within the infusion circuit, as previ-
ously hypothesized.8 The conductance of wider bore cath-
eters was reduced by approximately 20% by adding the
patient line extension, and this could have notable clini-
cal implications for centers that include the patient line
extension in their standard massive transfusion system.
Additionally, the lower flows afforded by the patient line
extension likely caused the infusate to cool, therefore
increasing viscosity and further decreasing flow. While
not tested in our study, Y-shaped extension tubing that
can connect a RID to two IV catheters is commercially
available. A system such as this would likely increase
flow and/or reduce driving pressure.
As anticipated, the rheological differences of R + F
reduced the flow capabilities of our infusion circuit as
compared to NS; however, the impact was clinically
significant only in large bore catheters. A previous model
incorporating NS, RBCs, and a Level 1 RID to assess pedi-
atric IV catheters achieved equivalent maximum flow
rates to those observed in the current study when NS was
infused through comparable cannulae.9 However, the
flow rates attained in our study using R + F (approximate
hematocrit of 27.5%) were higher than theirs using RBCs
(reported hematocrit of 70%), likely due to the propor-
tional effect of hematocrit on viscosity.10 A clinical corre-
late to this point would be the order in which blood
products are administered during hemostatic resuscita-
tion. In many centers, massive transfusion blood prod-
ucts are delivered in approximately a 1:1 ratio of FFP and
RBCs; as such it may be beneficial to maximum achiev-
able flow rates to add these in an alternating fashion to
the RID reservoir, rather than sequentially.
A decrease in temperature from 36.5°C to 22.0°C has
been shown to increase viscosity by 26.13% in blood.11 Beebe
et al9 documented a temperature of 27.1°C in their infused
RBCs using a Level 1 brand RID. The Belmont RID used in
this study affords greater efficiency at warming fluids to
physiologic temperatures at high flow rates,12 potentially
contributing to the higher flow rates achieved here.
Due to its ability to influence the laminarity of flow,
catheter material has been suggested to affect flow rates2;
therefore, the lack of an independent association between
material and conductance was surprising. Fluorinated
ethylene propylene (FEP) has a lower coefficient of fric-
tion than polyurethane (PU),1 so in theory it should
achieve greater flows. This may be attributable to con-
founding because the catheters composed of PU were
also the wider bore catheters.
A limitation of our in vitro model was our inability to
account for downstream pressure at the point at which
infused fluids enter the venous system of the patient. The
differential between the driving pressure generated by
the RID and downstream pressure is what generates flow,
and in our model this was at atmospheric pressure.
A previous study employed the use of a standing water
TABLE 4 Multiple linear regression of factors affecting conductance
Catheter
Unstandardized coefficients Standardized coefficients
p valueB SE β Lower 95% CI Upper 95% CI
Internal radius 4.656 0.186 1.098 4.286 5.025 <.001
Catheter length -0.007 0.001 −0.540 −0.008 −0.006 <.001
Catheter lumen −0.051 0.131 −0.014 −0.210 0.312 .697
Infusate −0.343 0.107 −0.107 −0.556 −0.130 .002
Extension line −0.300 0.107 −0.094 −0.513 −0.087 .006
Catheter material 0.254 0.165 0.067 −0.078 0.587 .132
Note: Reference categories for categorical variables were distal lumen for catheter lumen, normal saline (NS) for Infusate, no patient line extension for
extension line, and fluorinated ethylene propylene (FEP) for catheter material.
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column at 10 cm H2O to represent this pressure,
2 but our
access to blood products was limited and this would have
prevented us from employing our recirculation tech-
nique. Other models calculated flow by measuring the
volume infused over 30 s.9 This method would lead to an
underestimation of maximum flow rates using the Bel-
mont as it accelerates flow until the desired rate has been
reached or it becomes restricted by pressure limitation.
Again, this would also have precluded our recirculation
technique. Previous studies also compared their findings
with the manufacturer's quoted maximum flow rates4;
however, our use of the RID and wide bore tubing render
this comparison less meaningful.
Early work noted a pressure of approximately 8 mmHg
in superficial veins of the median cubital fossa.13 Experience
and physiological first principles suggest that in the
volume-depleted patient this would be much reduced; how-
ever, peripheral venous pressure may be higher than antici-
pated during hypovolemic shock due to segmental
constriction of the veins.14 The 7-Fr RIC achieved the sec-
ond highest conductance of the lines assessed, greater than
the 9-Fr sheath or the Trialysis catheter. However, given
that the RIC is inserted peripherally and the others cen-
trally, it is possible that it would be subjected to greater
back pressure in vivo and as such our model may have
overestimated its flow rate relative to the other catheters.
With many of the wide bore catheters achieving the maxi-
mum flow rates the RID could deliver, the conversion to
conductance served a useful function as it permitted rank-
ing of the catheters. While variations in pressure required
to achieve 1000 ml/min may not be clinically significant,
once downstream pressure is encountered in vivo they may
become so. Nonetheless, the short 7-Fr RIC catheter may
provide an equivalent flow rate to a wide-bore central
venous catheter in patients with conditions associated with
vasodilation undergoing procedures with a high risk of
major hemorrhage, such as obstetric patients or liver trans-
plant recipients.
Our study builds upon recent work performed by
Berman et al5 who analyzed the flow of blood products
through similar catheters. While this group arrived at
similar conclusions to ours, individual blood products at
room temperature were employed. The use of warmed,
mixed blood products, via a RID in the current study may
better represent the clinical conditions encountered dur-
ing massive transfusions.
Our RIDs were up to date in servicing and the manufac-
turer notes that no regular calibration is required. Nonethe-
less, we analyzed each configuration of the infusion circuit
on three separate RIDs. While this should have minimized
the potential for experimental error and the effect of any
imprecisions in the flow, pressure, or temperature sensors
of the RIDs, independent measurements of these
parameters were not performed. Therefore, we are unable
to rule out internal inaccuracies caused by variation in RID
function. Likewise, independent measurements of catheter
ID were not performed. Thus, we cannot rule out inaccura-
cies in the manufacturer-stated inside diameter, which may
have affected our calculation of conductance.
Use of expired blood products and their recirculation
back into the RID reservoir enabled us to perform this trial
efficiently, with no wastage of a valuable resource.
Although the storage lesion present in products of this age
is likely to have affected the membranes of our RBCs and
the biochemical constituency of the suspending solution,15
it is unclear how this would impact the rheology of our
products. Studies have shown a negative effect of older
RBCs on in vivo blood flow through alterations in microvas-
cular structure16 but there are no data on the ex vivo
hemorheology of expired products. Lastly, we cannot rule
out the occurrence of cell lysis during the recirculation
experiment because assessment of RBC stability, such as
serial hematocrit measurements, was not performed.
We evaluated a commercially available RID and
wide catheter selection using a commonly transfused
ratio of RBCs and FFP in our study. However, our find-
ings may not directly apply to centers using different
devices, different blood product processing methods,
or favoring a transfusion ratio other than 1:1 RBC:FFP.
In addition, we did not study the limitations to flow
that would be predicted by insertion of catheters or
central pressure monitors into the 9-Fr sheath or 9-Fr
MAC catheters. We anticipate that future studies uti-
lizing alternative systems will produce different flows
and/or pressures that will be consistent with our find-
ings overall.
To our knowledge, there are no other studies evaluat-
ing IV catheter performance using blood products in
ratios typically seen during massive transfusion in
trauma, obstetric, or surgical resuscitation. Data pres-
ented here may help clinicians deliver optimal hemo-
static resuscitation of critically bleeding patients by
maximizing the achievable blood product flow rate.
ACKNOWLEDGMENTS
The authors would like to thank the Blood Bank at
Zuckerberg San Francisco General Hospital and Trauma
Center for providing the expired blood products used in the
project.
CONFLICT OF INTEREST
Milne (None); Teng (None); Vargas (None); Markley
(None); Collins (None).
ORCID
John C. Markley https://orcid.org/0000-0002-2180-5604
MILNE ET AL. 7
REFERENCES
1. Reddick AD, Ronald J, Morrison WG. Intravenous fluid resus-
citation: was Poiseuille right? Emerg Med J. 2011;28:201–2.
2. McPherson D, Adekanye O, Wilkes AR, Hall JE. Fluid flow
through intravenous cannulae in a clinical model. Anesth
Analg. 2009;108:1198–202.
3. Jayanthi NV, Dabke HV. The effect of IV cannula length on
the rate of infusion. Injury. 2006;37:41–5.
4. Khoyratty SI, Gajendragadkar PR, Polisetty K, Ward S,
Skinner T, Gajendragadkar PR. Flow rates through intravenous
access devices: an in vitro study. J Clin Anesth. 2016;31:101–5.
5. Berman DJ, Schiavi A, Frank SM, Duarte S, Schwengel DA,
Miller CR. Factors that influence flow through intravascular
catheters: the clinical relevance of Poiseuille's law. Transfusion.
2020;60:1410–7.
6. Dinenno FA, Jones PP, Seals DR, Tanaka H. Limb blood flow
and vascular conductance are reduced with age in healthy
humans: relation to elevations in sympathetic nerve activity
and declines in oxygen demand. Circulation. 1999;100:164–70.
7. Cross GD. Evaluation of 3-mm diameter intravenous tubing for
the rapid infusion of fluids. Arch Emerg Med. 1987;4:173–7.
8. Mateer JR, Thompson BM, Tucker J, Aprahamian C, Darin JC.
Effects of high infusion pressure and large-bore tubing on
intravenous flow rates. Am J Emerg Med. 1985;3:187–9.
9. Beebe DS, Beck D, Belani KG. Comparison of the flow rates of
central venous catheters designed for rapid transfusion in
infants and small children. Paediatr Anaesth. 1995;5:35–9.
10. Hudak ML, Koehler RC, Rosenberg AA, Traystman RJ,
Jones MD Jr. Effect of hematocrit on cerebral blood flow.
Am J Physiol. 1986;251:H63–70.
11. Cinar Y, Senyol AM, Duman K. Blood viscosity and blood pres-
sure: role of temperature and hyperglycemia. Am J Hypertens.
2001;14:433–8.
12. Comunale ME. A laboratory evaluation of the level 1 rapid
infuser (H1025) and the Belmont instrument fluid manage-
ment system (FMS 2000) for rapid transfusion. Anesth Analg.
2003;97:1064–9.
13. Ochsner A Jr, Colp R Jr, Burch GE. Normal blood pressure in
the superficial venous system of man at rest in the supine posi-
tion. Circulation. 1951;3:674–80.
14. Weil MH, Shubin H, Rosoff L. Fluid repletion in circulatory
shock: central venous pressure and other practical guides.
JAMA. 1965;192:668–74.
15. Tsai AG, Hofmann A, Cabrales P, Intaglietta M. Perfusion vs.
oxygen delivery in transfusion with "fresh" and "old" red blood
cells: the experimental evidence. Transfus Apher Sci. 2010;43:
69–78.
16. Chin-Yee I, Arya N, d'Almeida MS. The red cell storage lesion
and its implication for transfusion. Transfus Sci. 1997;18:447–58.
How to cite this article: Milne A, Teng JJ,
Vargas A, Markley JC, Collins A. Performance
assessment of intravenous catheters for massive
transfusion: A pragmatic in vitro study.
Transfusion. 2021;1–8. https://doi.org/10.1111/trf.
16399
8 MILNE ET AL.
